Novavax partners with Takeda to deliver COVID-19 vaccine in Japan

US biotechnology company Novavax has signed a deal with Takeda Pharmaceuticals to develop, manufacture and market a COVID-19 vaccine in Japan, it was announced on Friday, August 7.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Generics

Second Circuit says Takeda can’t dodge two antitrust suits

26 August 2021 The US Court of Appeals for the Second Circuit has denied an appeal from Takeda Pharmaceuticals to shut down two antitrust suits related to its diabetes drug Actos.

Generics

A new drug pricing system reform proposal in Japan

17 August 2021 A Japanese think tank is recommending an overhaul of Japan’s drug pricing system. Takanori Abe of Abe and Partners reports.

Biotechnology

Novavax seals COVID-19 vaccine deal with Australia

5 November 2020 Australia has secured 40 million doses of a COVID-19 vaccine candidate in a deal with US biotechnology company Novavax.

More on this story

Generics

Second Circuit says Takeda can’t dodge two antitrust suits

26 August 2021 The US Court of Appeals for the Second Circuit has denied an appeal from Takeda Pharmaceuticals to shut down two antitrust suits related to its diabetes drug Actos.

Generics

A new drug pricing system reform proposal in Japan

17 August 2021 A Japanese think tank is recommending an overhaul of Japan’s drug pricing system. Takanori Abe of Abe and Partners reports.

Biotechnology

Novavax seals COVID-19 vaccine deal with Australia

5 November 2020 Australia has secured 40 million doses of a COVID-19 vaccine candidate in a deal with US biotechnology company Novavax.

More on this story

Generics

Second Circuit says Takeda can’t dodge two antitrust suits

26 August 2021 The US Court of Appeals for the Second Circuit has denied an appeal from Takeda Pharmaceuticals to shut down two antitrust suits related to its diabetes drug Actos.

Generics

A new drug pricing system reform proposal in Japan

17 August 2021 A Japanese think tank is recommending an overhaul of Japan’s drug pricing system. Takanori Abe of Abe and Partners reports.

Biotechnology

Novavax seals COVID-19 vaccine deal with Australia

5 November 2020 Australia has secured 40 million doses of a COVID-19 vaccine candidate in a deal with US biotechnology company Novavax.